Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease

Area of Science:

• Hepatology
• Pediatric Gastroenterology
• Metabolic Disorders

Background:

• Nonalcoholic fatty liver disease (NAFLD) encompasses a range of liver conditions, from steatosis to cirrhosis.
• NAFLD prevalence is increasing globally, paralleling the obesity pandemic, and is the leading cause of chronic liver disease in children.
• Childhood NAFLD suggests unique susceptibilities and potentially more severe long-term health consequences.

Purpose of the Study:

• To review the current understanding of early-onset NAFLD in children and adolescents.
• To highlight the complex pathogenesis and challenges in diagnosis and treatment.
• To emphasize the need for improved diagnostic tools and therapeutic strategies.

Main Methods:

• Review of existing literature on pediatric NAFLD.
• Analysis of factors contributing to NAFLD pathogenesis in early-onset cases.
• Discussion of current therapeutic interventions and future research directions.

Main Results:

• NAFLD is the most common chronic liver disease in children worldwide.
• Pathogenesis involves a complex interplay of genetic, metabolic, environmental, and microbiological factors, potentially starting in utero.
• Dietary and lifestyle modifications are primary treatments, but adherence is a challenge.

Conclusions:

• Pediatric NAFLD has significant implications due to potential long-term consequences.
• Non-invasive biomarkers and advanced imaging are needed for better diagnosis and natural history studies.
• Further research is essential for developing effective therapeutic interventions for childhood NAFLD.